Advisory Board

CH3 BioSystems has assembled an Advisory Board led by internationally recognized researchers and industry leaders. The Advisory Board works closely with the Directors to provide oversight on a regular basis regarding business strategy, legal issues, organizational development, technology, and regulatory policy.

Paul Buckley
Applied Sciences Group, Inc.


Lyn Dyster
Vice President of Operations
Kinex Pharmaceuticals


William E. Grieshober, Jr.
Vice President and Deputy General Counsel
Rich Products Corporation

James C.D. Hengst
President and CEO
ZeptoMetrix Corporation


Marnie LaVigne
Director, Business Development
UB Center for Advanced Biomedical and Bioengineering Technology
New York State Center of Excellence in Bioinformatics & Life Sciences